15 December 2022

Coulter Partners shares top global hires for large-cap, mid-cap and public companies H2-2022

Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, shares its recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

CEO/ C suite/ Board:
  • Chief Technology Officer, Biomanufacturer (mid-cap), US
  • Chief Medical Officer, Biotech (mid-cap), Europe
  • Chief Financial Officer, Surgical precision solutions (publicly listed), Europe
  • Chief Commercial Officer, Biotech (publicly listed), Canada/ US
  • Board Director, Biopharma (publicly listed), US
  • Board Director, Biotech (publicly listed), Canada
  • Board Director, Medical devices (publicly listed), US

Commercial / Functional / Strategic Leadership:
  • Head Business Development & Strategy, Phytopharmaceutical products (mid-cap), Europe
  • Head of Commercial Biologics, Contract development and manufacturing organization (publicly listed), US
  • Head of Global Marketing, Pharma (family-owned mid-cap), Europe
  • VP Marketing, Biotech (mid-cap), US
  • VP Government Affairs & Health Economics, Surgical products (mid-cap), Europe
  • VP Finance, Biopharma (mid-cap), Europe
  • General Manager Pulmonary, Advanced diagnostics (publicly listed), US
  • General Manager Poland, Medical devices & instruments (large-cap), Europe
  • Associate Director to the Senior Management Team, Pharma (top 10 global), Europe
  • Marketing Director EMEA, Medtech (large-cap), Europe/ APAC
  • Industrial Operations Corporate Director, Animal health pharma (top 5 global), Europe

R&D/ Medical/ Technical:
  • Global Head of Drug Design, Biopharma (large-cap), Europe
  • Group Head of Regulatory Affairs, Pharma (mid-cap), Europe
  • Global Head of R&D, Women's health (mid-cap), US
  • Chief Research & Innovation Officer, FMCG (large-cap), Europe
  • Head of Chemistry, Specialty pharma (mid-cap), Europe
  • Head of Clinical Development, Pharma (mid-cap), Europe
  • Head of Medical Affairs Europe and Japan, Drug delivery (mid-cap), Europe
  • EVP Technical Operations, Biopharma (publicly listed), US
  • Director Global QA Excellence, Surgical products (large-cap), Europe
  • Health Economist x 2, Medtech and industrial services (large-cap), Europe

 

Related topics